Elbit Imaging Ltd.

Elbit Imaging Ltd.

EMITF
Elbit Imaging Ltd.US flagOther OTC
1.60
USD
- -
- -
21.25MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.74
50.35
25.27
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.06
4.14
Basic EPS, GAAP
-2,784.91
127.46
-23.51
-21.2
-36.78
-56.34
-11.7
25.01
-2.24
-0.26
-0.27
-0.5
-0.43
-0.41
Free Cash Flow per Basic Share
33.51
34.94
21.18
8.07
46.75
-2.21
-1.61
-1.7
-0.37
-0.04
-0.04
-0.05
0.54
-0.19
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.27
1.11
0.14
- -
- -
- -
Book Value per Share
-384.61
124.8
111.32
76.08
73.51
17.45
5.79
30.8
28.35
27.53
-0.89
5.43
5.45
5.79
Tangible Book Value per Share
-2,488.49
29.31
38.4
5.29
-16.19
-6.54
-18.41
10.28
7.74
6.92
-0.07
6.42
7.06
7.27
Basic Weighted Avg Shares
- -
8
8
9
9
9
9
9
9
9
10
11
12
13
Sales/Revenue/Turnover
2
399
200
- -
- -
- -
- -
- -
- -
- -
- -
- -
38
55
Operating Margin (%)
-2,900.71
-26.84
-53.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
-6.29
2.07
Depreciation Expense
4
583
123
196
120
113
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1,156
1,009
-186
-195
-338
-518
-107
230
-20
-2
-3
-5
-5
-5
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-58,811.45
253.15
-93.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
-14.03
-9.93
Working Capital
-2,694
102
-589
-1,031
-363
-110
-108
-3
21
35
- -
68
-18
57
LT Debt
- -
756
1,444
853
243
145
159
- -
- -
- -
2
2
71
137
Total Equity
-1,033
232
304
49
-149
-60
-169
94
71
63
-1
68
87
97
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-19.92
-24.65
-49.17
-123.88
-100.66
136.71
-7.55
-0.93
-7.47
- -
-8.47
-14.22

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
187
172
125
LT Borrowings
71
71
137
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
70
2
75

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
204
194
214
Cash, Cash Equivalents & STI
149
145
163
Accounts Receivable, Net
3
- -
4
Inventories
- -
- -
- -
Total Current Liabilities
224
212
157
Payables & Accruals
- -
- -
- -
ST Debt
187
172
125
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1,055.57%
-2,006.34%
27.1%
Free Cash Flow
- -
- -
-1,244.16%
Net Income, GAAP
-34.59%
-16.83%
-0.71%
Sales/Revenue/Turnover
- -
- -
-81.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
24
14
38
2026
17
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.06
- -
- -
-0.5
2025
-0.15
- -
-0.15
- -
-0.43
2026
-0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Ron Hadassi
Full Time Employees
20
Sector
Real Estate
Industry
Real Estate - Development
Address
Masada 9 Bnei Brak WA Israel 5120109
IPO Date
Nov 27, 1996
Business
Elbit Imaging Ltd. operates as an Israeli holding entity with a diversified portfolio spanning real estate and advanced medical industries. Through its various subsidiaries, the company is actively engaged in the research, development, production, and global distribution of sophisticated therapeutic medical systems. These innovative solutions leverage magnetic resonance imaging (MRI)-guided focused ultrasound technology for non-invasive treatments across the human body. Furthermore, its medical industry interests include the advancement of stem cell population expansion technologies and the creation of stem cell therapy products, intended for transplantation and regenerative medicine to address various conditions such as certain types of cancer and blood disorders. The geographical reach for its medical systems extends across North and South America, Europe, Asia, and Oceania. Concurrently, the company maintains substantial involvement in real estate, encompassing the initiation, construction, and sale of commercial centers, hotel operations, and residential developments. These property ventures are primarily concentrated in Central and Eastern Europe and India, with a focus on plots designated for residential projects. Founded in 1996, Elbit Imaging Ltd. is headquartered in Petach Tikva, Israel.